Improving the Affordability of Prescription Drugs for Medicare Beneficiaries

This Viewpoint assesses the affordability of traditional Medicare and Medicare Advantage Part D prescription drug benefits in the context of changes by the Inflation Reduction Act.

Authors

Institutions

Publication Details

Journal
JAMA Internal Medicine
Published
2024-12-23
DOI
https://doi.org/10.1001/jamainternmed.2024.6915
Citations
2
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
2.26
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Improving the Affordability of Prescription Drugs for Medicare Beneficiaries

Stacie B. Dusetzina
2 citations
JAMA Internal Medicine
Pharmaceutical Economics and Policy
2.26
article

Improving the Affordability of Prescription Drugs for Medicare Beneficiaries

Stacie B. Dusetzina
article en
2 citations

Abstract

This Viewpoint assesses the affordability of traditional Medicare and Medicare Advantage Part D prescription drug benefits in the context of changes by the Inflation Reduction Act.

JAMA Internal MedicineVol. 185(3)
Vanderbilt University (US), Vanderbilt Health (US), Vanderbilt-Ingram Cancer Center
Decent work and economic growth
Openalex Percentile: Top 7%
Pharmaceutical Economics and Policy
2.26
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Improving the Affordability of Prescription Drugs for Medicare Beneficiaries — Stacie B. Dusetzina · JAMA Internal Medicine (2024) | TGRS Research Map | TGRS